v3.26.1
Consolidated Statements of Cash Flows (Parenthetical) - USD ($)
$ in Thousands
6 Months Ended
Jun. 30, 2026
Jun. 30, 2025
Reconciliation of cash and cash equivalents and restricted cash presented on the consolidated statements of cash flows    
Cash and cash equivalents $ 15,922 [1] $ 13,907
Restricted cash 10,182 [1] 9,030
Total cash and cash equivalents and restricted cash 26,104 22,937
Supplemental disclosure of non-cash investing and financing activity:    
Dividends declared to common shareholders 12,754 12,789
Non-cash interest accrued to debt balances 2,179 2,123
Accrued loan acquisition costs 173 $ 1,525
Accrued acquisition costs $ 1,145  
[1] Refer to Note 2 for details on the Company’s consolidated variable interest entities (“VIEs”).